Pharmacists in Durham, North Carolina
433 Pharmacists found in Durham
Matthew James Smith, RPH
Pharmacist
2300 Englert Dr Ste A, Homechoice Partners Home Infusion, Durham, NC 27713
919-433-5180 919-433-5199
Dr. Matthew Aaron Fowler, PHARMD
Pharmacist
2816 Erwin Rd Ste 105, Durham, NC 27705
919-282-5553 919-864-4900
Melanie Suzanne Kolasa, PHARMD
Pharmacist
200 S Lasalle Street, C/o Rite Aid Pharmacy, Durham, NC 27705
919-383-5591
Dr. Melanie Lewis Evans, PHARMD
Pharmacist - Pharmacotherapy
4022 Stirrup Creek Dr, Ste 325, Durham, NC 27703
919-484-2229
Melanie Rae Nicol, PHARMD
Pharmacist
1109 W Nc Highway 54, Durham, NC 27707
919-403-8059 919-409-8475
Melanie Tess Mahoney, PHARMD, CPP, MPH
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
40 Duke Medicine Cir # 2f2g, Durham, NC 27710
919-681-6155
Dr. Melinda L Simons, PHARMD
Pharmacist
1821 Hillandale Rd, Kerr Drug 408, Durham, NC 27705
919-383-0820 919-382-7467
Dr. Melissa Michelle Mullis, PHARMD
Pharmacist
101 W Woodcroft Pkwy, Durham, NC 27713
919-484-8817 919-572-1938
Dr. Melissa Ann Durkee, PHARMD
Pharmacist - Pharmacotherapy
508 Fulton St, Durham, NC 27705
919-286-0411 919-286-6987
Dr. Melissa Ann Hall, PHARMD, RPH
Pharmacist
5311 N Roxboro Rd, Durham, NC 27712
919-471-4409 919-620-9639
Miss Meredith Toma Moorman, PHARM. D.
Pharmacist - Oncology
1 Trent Drive, Box 3089, Durham, NC 27710
919-681-2414
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.